| cellular process (GO:0009987) | 0.26 | 9 | CRB2, ANLN, CD2AP, INF2, TRPC6, PAX2, APOL1, MYO1E, ACTN4 |
| biological regulation (GO:0065007) | 0.39 | 9 | CRB2, ANLN, CD2AP, INF2, TRPC6, PAX2, APOL1, MYO1E, ACTN4 |
| single-organism process (GO:0044699) | 0.48 | 9 | CRB2, ANLN, CD2AP, INF2, TRPC6, PAX2, APOL1, MYO1E, ACTN4 |
| single-organism cellular process (GO:0044763) | 0.65 | 8 | CRB2, ANLN, CD2AP, INF2, TRPC6, PAX2, MYO1E, ACTN4 |
| regulation of biological process (GO:0050789) | 0.45 | 8 | CRB2, ANLN, CD2AP, INF2, TRPC6, PAX2, MYO1E, ACTN4 |
| regulation of cellular process (GO:0050794) | 0.5 | 8 | CRB2, ANLN, CD2AP, INF2, TRPC6, PAX2, MYO1E, ACTN4 |
| regulation of cellular component organization (GO:0051128) | 2.01 | 7 | CRB2, ANLN, CD2AP, INF2, TRPC6, PAX2, ACTN4 |
| cellular component organization (GO:0016043) | 1.24 | 6 | INF2, ANLN, CD2AP, PAX2, MYO1E, ACTN4 |
| cellular component organization or biogenesis (GO:0071840) | 1.22 | 6 | INF2, ANLN, CD2AP, PAX2, MYO1E, ACTN4 |
| regulation of developmental process (GO:0050793) | 2.1 | 5 | CRB2, ACTN4, INF2, TRPC6, PAX2 |
| positive regulation of biological process (GO:0048518) | 1.2 | 5 | ACTN4, PAX2, CD2AP, CRB2, TRPC6 |
| regulation of anatomical structure morphogenesis (GO:0022603) | 2.79 | 5 | CRB2, ACTN4, INF2, TRPC6, PAX2 |
| negative regulation of biological process (GO:0048519) | 1.33 | 5 | ACTN4, CRB2, CD2AP, PAX2, TRPC6 |
| regulation of cell morphogenesis (GO:0022604) | 3.4 | 4 | CRB2, ACTN4, PAX2, TRPC6 |
| regulation of primary metabolic process (GO:0080090) | 1.08 | 4 | PAX2, ACTN4, CRB2, TRPC6 |
| regulation of metabolic process (GO:0019222) | 1.02 | 4 | PAX2, ACTN4, CRB2, TRPC6 |
| cell differentiation (GO:0030154) | 2.14 | 4 | ANLN, TRPC6, MYO1E, PAX2 |
| regulation of cellular metabolic process (GO:0031323) | 1.07 | 4 | PAX2, ACTN4, CRB2, TRPC6 |
| movement of cell or subcellular component (GO:0006928) | 2.61 | 4 | CD2AP, ANLN, ACTN4, MYO1E |
| metabolic process (GO:0008152) | 0.58 | 4 | PAX2, CD2AP, APOL1, MYO1E |
| signal transduction (GO:0007165) | 1.28 | 4 | ACTN4, PAX2, CD2AP, MYO1E |
| cellular developmental process (GO:0048869) | 1.82 | 4 | ANLN, TRPC6, MYO1E, PAX2 |
| regulation of cell development (GO:0060284) | 3.01 | 4 | CRB2, ACTN4, PAX2, TRPC6 |
| regulation of cell morphogenesis involved in differentiation (GO:0010769) | 3.91 | 4 | CRB2, ACTN4, PAX2, TRPC6 |
| regulation of molecular function (GO:0065009) | 1.78 | 4 | CRB2, ACTN4, PAX2, TRPC6 |
| developmental process (GO:0032502) | 1.36 | 4 | CRB2, TRPC6, MYO1E, PAX2 |
| regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 4 | CRB2, ACTN4, PAX2, TRPC6 |
| transport (GO:0006810) | 1.51 | 4 | ACTN4, APOL1, TRPC6, MYO1E |
| single-organism developmental process (GO:0044767) | 1.49 | 4 | PAX2, CRB2, TRPC6, MYO1E |
| response to stress (GO:0006950) | 1.8 | 4 | PAX2, ACTN4, APOL1, TRPC6 |
| regulation of multicellular organismal process (GO:0051239) | 1.87 | 4 | PAX2, CD2AP, CRB2, TRPC6 |
| establishment of localization (GO:0051234) | 1.48 | 4 | ACTN4, APOL1, TRPC6, MYO1E |
| localization (GO:0051179) | 1.4 | 4 | ACTN4, APOL1, TRPC6, MYO1E |
| response to stimulus (GO:0050896) | 1.22 | 4 | PAX2, ACTN4, APOL1, TRPC6 |
| regulation of cell differentiation (GO:0045595) | 2.42 | 4 | CRB2, ACTN4, PAX2, TRPC6 |
| negative regulation of cellular process (GO:0048523) | 1.41 | 4 | PAX2, ACTN4, CRB2, TRPC6 |
| positive regulation of cellular process (GO:0048522) | 1.3 | 4 | CRB2, ACTN4, PAX2, TRPC6 |
| cellular component assembly (GO:0022607) | 2.14 | 3 | ACTN4, ANLN, CD2AP |
| regulation of organelle organization (GO:0033043) | 2.72 | 3 | ANLN, CD2AP, INF2 |
| regulation of transport (GO:0051049) | 2.24 | 3 | ACTN4, CD2AP, TRPC6 |
| positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 3 | PAX2, CRB2, TRPC6 |
| negative regulation of multicellular organismal process (GO:0051241) | 2.84 | 3 | PAX2, CD2AP, TRPC6 |
| regulation of protein metabolic process (GO:0051246) | 1.93 | 3 | PAX2, CRB2, TRPC6 |
| organic substance metabolic process (GO:0071704) | 0.63 | 3 | PAX2, CD2AP, APOL1 |
| positive regulation of cell development (GO:0010720) | 3.57 | 3 | CRB2, PAX2, TRPC6 |
| regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 3 | CRB2, ACTN4, PAX2 |
| regulation of biological quality (GO:0065008) | 1.68 | 3 | PAX2, APOL1, TRPC6 |
| positive regulation of cellular component organization (GO:0051130) | 2.68 | 3 | CRB2, ACTN4, PAX2 |
| negative regulation of developmental process (GO:0051093) | 3.17 | 3 | PAX2, ACTN4, TRPC6 |
| multicellular organismal process (GO:0032501) | 1.45 | 3 | PAX2, CRB2, MYO1E |
| actin filament-based process (GO:0030029) | 3.94 | 3 | INF2, ACTN4, MYO1E |
| regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 3 | CRB2, ACTN4, PAX2 |
| regulation of biosynthetic process (GO:0009889) | 1.37 | 3 | PAX2, ACTN4, CRB2 |
| regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 3 | CRB2, ACTN4, PAX2 |
| positive regulation of cell differentiation (GO:0045597) | 3.01 | 3 | PAX2, CRB2, TRPC6 |
| regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 3 | CRB2, ACTN4, PAX2 |
| regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 3 | CRB2, ACTN4, PAX2 |
| regulation of localization (GO:0032879) | 1.94 | 3 | CD2AP, ACTN4, TRPC6 |
| organelle organization (GO:0006996) | 2.02 | 3 | ANLN, CD2AP, INF2 |
| primary metabolic process (GO:0044238) | 0.69 | 3 | PAX2, CD2AP, APOL1 |
| regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 3 | CRB2, PAX2, TRPC6 |
| vesicle-mediated transport (GO:0016192) | 2.72 | 3 | ACTN4, APOL1, MYO1E |
| single-multicellular organism process (GO:0044707) | 1.78 | 3 | CRB2, PAX2, MYO1E |
| positive regulation of developmental process (GO:0051094) | 2.77 | 3 | CRB2, PAX2, TRPC6 |
| anatomical structure development (GO:0048856) | 1.58 | 3 | CRB2, PAX2, MYO1E |
| macromolecule metabolic process (GO:0043170) | 0.83 | 3 | PAX2, CD2AP, APOL1 |
| regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 3 | CRB2, ACTN4, PAX2 |
| regulation of multicellular organismal development (GO:2000026) | 2.31 | 3 | PAX2, CRB2, TRPC6 |
| regulation of RNA metabolic process (GO:0051252) | 1.52 | 3 | CRB2, ACTN4, PAX2 |
| positive regulation of response to stimulus (GO:0048584) | 2.18 | 2 | CRB2, ACTN4 |
| regulation of response to stimulus (GO:0048583) | 1.54 | 2 | CRB2, ACTN4 |
| positive regulation of transmembrane transport (GO:0034764) | 4.99 | 2 | ACTN4, TRPC6 |
| regulation of ion transmembrane transport (GO:0034765) | 3.77 | 2 | ACTN4, TRPC6 |
| positive regulation of ion transmembrane transport (GO:0034767) | 5.05 | 2 | ACTN4, TRPC6 |
| organic cyclic compound metabolic process (GO:1901360) | 1.26 | 2 | PAX2, APOL1 |
| cellular response to stimulus (GO:0051716) | 1.97 | 2 | PAX2, TRPC6 |
| negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 2 | CRB2, PAX2 |
| positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 2 | PAX2, TRPC6 |
| regulation of signal transduction (GO:0009966) | 1.84 | 2 | CRB2, ACTN4 |
| positive regulation of signal transduction (GO:0009967) | 2.5 | 2 | CRB2, ACTN4 |
| kidney development (GO:0001822) | 4.79 | 2 | PAX2, MYO1E |
| transmembrane transport (GO:0055085) | 2.72 | 2 | APOL1, TRPC6 |
| animal organ development (GO:0048513) | 2.53 | 2 | PAX2, MYO1E |
| positive regulation of molecular function (GO:0044093) | 2.23 | 2 | ACTN4, TRPC6 |
| negative regulation of molecular function (GO:0044092) | 2.74 | 2 | PAX2, CRB2 |
| cellular homeostasis (GO:0019725) | 3.23 | 2 | PAX2, TRPC6 |
| positive regulation of transport (GO:0051050) | 2.9 | 2 | ACTN4, TRPC6 |
| actin filament-based movement (GO:0030048) | 5.54 | 2 | ACTN4, MYO1E |
| regulation of proteolysis (GO:0030162) | 3.2 | 2 | CRB2, PAX2 |
| regionalization (GO:0003002) | 4.24 | 2 | CRB2, PAX2 |
| response to inorganic substance (GO:0010035) | 3.56 | 2 | PAX2, TRPC6 |
| system process (GO:0003008) | 2.3 | 2 | PAX2, MYO1E |
| cell motility (GO:0048870) | 3.02 | 2 | ANLN, CD2AP |
| chemical homeostasis (GO:0048878) | 2.97 | 2 | PAX2, TRPC6 |
| cellular response to stress (GO:0033554) | 2.51 | 2 | PAX2, TRPC6 |
| negative regulation of peptidase activity (GO:0010466) | 4.22 | 2 | CRB2, PAX2 |
| positive regulation of ion transmembrane transporter activity (GO:0032414) | 5.55 | 2 | ACTN4, TRPC6 |
| negative regulation of metabolic process (GO:0009892) | 1.93 | 2 | PAX2, CRB2 |
| positive regulation of metabolic process (GO:0009893) | 1.74 | 2 | PAX2, TRPC6 |
| regulation of ion transmembrane transporter activity (GO:0032412) | 4.55 | 2 | ACTN4, TRPC6 |
| response to reactive oxygen species (GO:0000302) | 4.5 | 2 | PAX2, TRPC6 |
| nitrogen compound metabolic process (GO:0006807) | 1.13 | 2 | PAX2, MYO1E |
| mitotic nuclear division (GO:0007067) | 4.05 | 2 | ANLN, CD2AP |
| regulation of apoptotic process (GO:0042981) | 2.5 | 2 | PAX2, ACTN4 |
| response to hypoxia (GO:0001666) | 4.13 | 2 | ACTN4, TRPC6 |
| negative regulation of hydrolase activity (GO:0051346) | 3.74 | 2 | PAX2, CRB2 |
| cellular macromolecule metabolic process (GO:0044260) | 0.93 | 2 | PAX2, CD2AP |
| macromolecular complex assembly (GO:0065003) | 2.55 | 2 | ANLN, CD2AP |
| regulation of transmembrane transport (GO:0034762) | 3.74 | 2 | ACTN4, TRPC6 |
| inorganic ion transmembrane transport (GO:0098660) | 3.38 | 2 | APOL1, TRPC6 |
| cell migration (GO:0016477) | 3.12 | 2 | ANLN, CD2AP |
| anatomical structure formation involved in morphogenesis (GO:0048646) | 3.01 | 2 | CRB2, PAX2 |
| ion transport (GO:0006811) | 2.66 | 2 | APOL1, TRPC6 |
| regulation of catalytic activity (GO:0050790) | 1.97 | 2 | CRB2, PAX2 |
| single-organism metabolic process (GO:0044710) | 1.63 | 2 | PAX2, APOL1 |
| system development (GO:0048731) | 2.92 | 2 | CRB2, PAX2 |
| regulation of hydrolase activity (GO:0051336) | 2.53 | 2 | PAX2, CRB2 |
| endocytosis (GO:0006897) | 3.69 | 2 | APOL1, MYO1E |
| response to hydrogen peroxide (GO:0042542) | 5.02 | 2 | PAX2, TRPC6 |
| regulation of transmembrane transporter activity (GO:0022898) | 4.52 | 2 | ACTN4, TRPC6 |
| regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 2 | PAX2, CRB2 |
| regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 2 | CRB2, PAX2 |
| negative regulation of cellular component organization (GO:0051129) | 3.35 | 2 | ACTN4, TRPC6 |
| positive regulation of signaling (GO:0023056) | 2.41 | 2 | CRB2, ACTN4 |
| cellular response to chemical stimulus (GO:0070887) | 2.57 | 2 | PAX2, TRPC6 |
| regulation of signaling (GO:0023051) | 1.72 | 2 | CRB2, ACTN4 |
| positive regulation of cell communication (GO:0010647) | 2.41 | 2 | CRB2, ACTN4 |
| regulation of cell communication (GO:0010646) | 1.73 | 2 | CRB2, ACTN4 |
| negative regulation of catalytic activity (GO:0043086) | 3.0 | 2 | CRB2, PAX2 |
| cell cycle (GO:0007049) | 3.14 | 2 | ANLN, CD2AP |
| positive regulation of transporter activity (GO:0032411) | 5.44 | 2 | ACTN4, TRPC6 |
| negative regulation of protein metabolic process (GO:0051248) | 2.82 | 2 | PAX2, CRB2 |
| anatomical structure morphogenesis (GO:0009653) | 2.53 | 2 | PAX2, CRB2 |
| nuclear division (GO:0000280) | 3.85 | 2 | ANLN, CD2AP |
| macromolecular complex subunit organization (GO:0043933) | 2.14 | 2 | ANLN, CD2AP |
| regulation of transporter activity (GO:0032409) | 4.45 | 2 | ACTN4, TRPC6 |
| locomotion (GO:0040011) | 2.91 | 2 | ANLN, CD2AP |
| cellular response to oxygen-containing compound (GO:1901701) | 3.22 | 2 | PAX2, TRPC6 |
| negative regulation of cell development (GO:0010721) | 4.02 | 2 | ACTN4, TRPC6 |
| regulation of vesicle-mediated transport (GO:0060627) | 3.63 | 2 | CD2AP, ACTN4 |
| positive regulation of ion transport (GO:0043270) | 4.36 | 2 | ACTN4, TRPC6 |
| negative regulation of cell differentiation (GO:0045596) | 3.33 | 2 | ACTN4, TRPC6 |
| cellular chemical homeostasis (GO:0055082) | 3.4 | 2 | PAX2, TRPC6 |
| response to oxidative stress (GO:0006979) | 3.9 | 2 | PAX2, TRPC6 |
| negative regulation of cellular protein metabolic process (GO:0032269) | 2.88 | 2 | CRB2, PAX2 |
| aging (GO:0007568) | 4.16 | 2 | PAX2, TRPC6 |
| response to decreased oxygen levels (GO:0036293) | 4.09 | 2 | ACTN4, TRPC6 |
| negative regulation of cell morphogenesis involved in differentiation (GO:0010771) | 4.96 | 2 | ACTN4, TRPC6 |
| positive regulation of cell morphogenesis involved in differentiation (GO:0010770) | 4.65 | 2 | CRB2, PAX2 |
| negative regulation of proteolysis (GO:0045861) | 3.98 | 2 | CRB2, PAX2 |
| cell projection organization (GO:0030030) | 3.14 | 2 | PAX2, CD2AP |
| positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 2 | PAX2, TRPC6 |
| negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 2 | CRB2, PAX2 |
| mitotic cell cycle process (GO:1903047) | 3.12 | 2 | ANLN, CD2AP |
| homeostatic process (GO:0042592) | 2.61 | 2 | PAX2, TRPC6 |
| cell cycle process (GO:0022402) | 2.75 | 2 | ANLN, CD2AP |
| regulation of cell death (GO:0010941) | 2.43 | 2 | PAX2, ACTN4 |
| multicellular organism development (GO:0007275) | 2.54 | 2 | PAX2, MYO1E |
| cell division (GO:0051301) | 3.68 | 2 | ANLN, CD2AP |
| pattern specification process (GO:0007389) | 3.79 | 2 | CRB2, PAX2 |
| protein complex subunit organization (GO:0071822) | 2.6 | 2 | ANLN, CD2AP |
| positive regulation of nervous system development (GO:0051962) | 3.64 | 2 | PAX2, TRPC6 |
| regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 2 | PAX2, CRB2 |
| regulation of programmed cell death (GO:0043067) | 2.49 | 2 | PAX2, ACTN4 |
| regulation of nervous system development (GO:0051960) | 3.1 | 2 | PAX2, TRPC6 |
| regulation of ion transport (GO:0043269) | 3.4 | 2 | ACTN4, TRPC6 |
| organic substance transport (GO:0071702) | 2.15 | 2 | ACTN4, APOL1 |
| regulation of gene expression (GO:0010468) | 1.37 | 2 | PAX2, CRB2 |
| cellular response to hydrogen peroxide (GO:0070301) | 5.65 | 2 | PAX2, TRPC6 |
| regulation of peptidase activity (GO:0052547) | 3.75 | 2 | CRB2, PAX2 |
| regulation of endopeptidase activity (GO:0052548) | 3.8 | 2 | PAX2, CRB2 |
| protein complex assembly (GO:0006461) | 2.78 | 2 | ANLN, CD2AP |
| cellular response to reactive oxygen species (GO:0034614) | 5.22 | 2 | PAX2, TRPC6 |
| regulation of metal ion transport (GO:0010959) | 3.94 | 2 | ACTN4, TRPC6 |
| ion transmembrane transport (GO:0034220) | 3.08 | 2 | APOL1, TRPC6 |
| single-organism transport (GO:0044765) | 2.18 | 2 | ACTN4, APOL1 |
| negative regulation of endopeptidase activity (GO:0010951) | 4.26 | 2 | CRB2, PAX2 |
| response to chemical (GO:0042221) | 1.98 | 2 | PAX2, TRPC6 |
| cellular response to oxidative stress (GO:0034599) | 4.7 | 2 | PAX2, TRPC6 |
| regulation of endocytosis (GO:0030100) | 4.42 | 2 | CD2AP, ACTN4 |
| single-organism localization (GO:1902578) | 2.09 | 2 | ACTN4, APOL1 |
| response to oxygen levels (GO:0070482) | 4.02 | 2 | ACTN4, TRPC6 |
| response to oxygen-containing compound (GO:1901700) | 2.57 | 2 | PAX2, TRPC6 |
| response to abiotic stimulus (GO:0009628) | 2.8 | 2 | ACTN4, TRPC6 |
| cytoskeleton organization (GO:0007010) | 3.22 | 2 | ANLN, INF2 |
| cellular metabolic process (GO:0044237) | 0.69 | 2 | PAX2, CD2AP |
| organelle fission (GO:0048285) | 3.79 | 2 | ANLN, CD2AP |